Information:
Error:
Keywords
Central Nervous System Neoplasms ×
- Clinical Trial (106)
- Brain Neoplasms (102)
- Treatment Form (25)
- On-Study Form (12)
- Follow-Up Studies (11)
- Eligibility Determination (9)
- Baseline (6)
- Radiotherapy (5)
- Off-Treatment (5)
- Pathology (5)
- Adverse event (4)
- Registration (4)
- Laboratories (3)
- Leukemia (3)
- Quality of Life (2)
- Radiology (2)
- HIV Infections (2)
- Disease Response (2)
- Death (2)
- Questionnaires (1)
- Salvage Therapy (1)
- Disease Notification (1)
- Child (1)
- Symptom Assessment (1)
- Document Tracking (1)
- Drug trial (1)
- Parkinsons Disease (1)
- Demography (1)
- HIV (1)
- Neoplasms (1)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
106 Search results.
Itemgroups: RTOG clinical trial administrative data, Patient status assessment, RECURRENCE OR PROGRESSION, Non-Protocol Therapy, Protocol Specific Adverse Event Evaluation1, Protocol Specific Adverse Event Evaluation2, Comments
Itemgroups: RTOG clinical trial administrative data, Various questionnaire related information, Cognition Quality of Life
Itemgroups: RTOG clinical trial administrative data, REPORT ALL CONTINUING OR NEW ADVERSE EVENTS
Itemgroups: Header, DLT Toxicity Data, Results of test completed during this weekly reporting interval, Comments, CCRR MODULE
Itemgroups: Header, Death Assessment, CCRR MODULE
Itemgroups: Header, Treatment period, TUMOR EVALUATION, DISEASE STATUS, EVALUATIONS, SIGNIFICANT EVENTS DURING THIS REPORTING PERIOD, TREATMENT PLAN AFTER THIS TREATMENT PERIOD, TOXICITIES, Comments, CCRR MODULE
Itemgroups: Reporting period, TUMOR EVALUATION, DISEASE STATUS, EVALUATIONS, SIGNIFICANT EVENTS DURING THIS REPORTING PERIOD, TREATMENT PLAN AFTER THIS TREATMENT PERIOD, TOXICITIES, Comments, CCRR MODULE
Itemgroups: Header, Secondary Malignancy, CCRR MODULE
Itemgroups: Header, Treatment related information, Diagnosis, Hemogram, Chemistries, Comments, CCRR MODULE
Itemgroups: Header, Anti-cancer therapy, Type of Prior Therapy, Comments, General Validations, CCRR MODULE
Itemgroups: Header, Relapse/Progression, CCRR MODULE
Itemgroups: Header, Sites of Measurable Disease at the Time of Study Entry, Evaluation of lesions, Comments, CCRR MODULE